(Therapeutic Development and Bioimaging thematic programmes of the Semmelweis University)
(2020-1.1.6-JOVO-2021-00013)
National Research, Development and Innovation Office (NKFIH) of Hungary(FK134751)
(ÚNKP-22-4-II-SE-3)
Az orvos-, egészségtudományi- és gyógyszerészképzés tudományos műhelyeinek fejlesztése(EFOP-3.6.3-VEKOP-16-2017-00009)
Támogató: EFOP-VEKOP
Szakterületek:
Gyógyszerészet, farmakogenomika, gyógyszerkutatás és tervezés, gyógyszeres kezelés
Duchenne muscular dystrophy (DMD) is characterized by wasting of muscles that leads
to difficulty moving and premature death, mainly from heart failure. Glucocorticoids
are applied in the management of the disease, supporting the hypothesis that inflammation
may be driver as well as target. However, the inflammatory mechanisms during progression
of cardiac and skeletal muscle dysfunction are still not well characterized. Our objective
was to characterize the inflammasomes in myocardial and skeletal muscle in rodent
models of DMD. Gastrocnemius and heart samples were collected from mdx mice and DMDmdx
rats (3 and 9–10 months). Inflammasome sensors and effectors were assessed by immunoblotting.
Histology was used to assess leukocyte infiltration and fibrosis. In gastrocnemius,
a tendency towards elevation of gasdermin D irrespective of the age of the animal
was observed. The adaptor protein was elevated in the mdx mouse skeletal muscle and
heart. Increased cleavage of the cytokines was observed in the skeletal muscle of
the DMDmdx rats. Sensor or cytokine expression was not changed in the tissue samples
of the mdx mice. In conclusion, inflammatory responses are distinct between the skeletal
muscle and heart in relevant models of DMD. Inflammation tends to decrease over time,
supporting the clinical observations that the efficacy of anti-inflammatory therapies
might be more prominent in the early stage.